15:27:20 EST Wed 06 Nov 2024
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

Q:ACOGF - ALPHA COGNITION INC - Website unknown - click to update
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
ACOGF - Qnot subscribed0.35    0.7398  0.1638Nov 04Oct 3115 min RT 2¢

Recent Trades - All 0 today
Time ETExPriceChangeVolume
     
     
     
     
     
     
     
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-10-31 08:30U:ACOGFNews ReleaseAlpha Cognition Announces Proposed Financing and Share Consolidation in connection with Nasdaq Uplisting
2024-10-21 08:30U:ACOGFNews ReleaseAlpha Cognition Announces Appointment of VP Finance and Accounting
2024-10-15 08:30U:ACOGFNews ReleaseAlpha Cognition Receives Notice of Allowance for Composition-of-Matter Patent for ZUNVEYLTM for Mild to Moderate Alzheimer's Disease
2024-10-03 19:00U:ACOGFNews ReleaseAlpha Cognition Announces Change of Officer
2024-09-24 17:16U:ACOGFNews ReleaseAlpha Cognition Announces Completion of $4.545 Million (USD) Convertible Note and Warrants Bridge Financing
2024-08-19 08:30U:ACOGFNews ReleaseAlpha Cognition Receives Notice of Allowance for Composition-of-Matter Patent for ZUNVEYL(TM) for Mild to Moderate Alzheimer's Disease
2024-08-13 17:02U:ACOGFNews ReleaseAlpha Cognition, Inc. On Track to Secure Financing for Continued Growth
2024-07-29 08:08U:ACOGFNews ReleaseAlpha Cognition's Oral Therapy ZUNVEYL(TM) Receives FDA Approval to Treat Alzheimer's Disease
2024-05-14 19:24U:ACOGFNews ReleaseAlpha Cognition Announces First Quarter of 2024 Results and Provides Corporate Update
2024-04-03 22:08U:ACOGFNews ReleaseAlpha Cognition Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update
2024-03-20 16:35U:ACOGFNews ReleaseAlpha Cognition to Present at the Emerging Growth Conference on April 3, 2024 at 12:00pm EDT.
2024-03-08 08:35U:ACOGFNews ReleaseLife Science Virtual Investor Forum Presentations Now Available for Online Viewing
2024-03-05 08:35U:ACOGFNews ReleaseLife Science Virtual Investor Forum Agenda Announced for March 7th, 2024
2024-03-01 07:54U:ACOGFNews ReleaseAlpha Cognition to Present at the Life Science Investor Forum March 7th
2024-02-22 08:30U:ACOGFNews ReleaseAlpha Cognition Files U.S. Patent Application Covering an ALPHA-1062 Oral Formulation to Treat Mild to Moderate Alzheimer ¢ € ™s Disease
2024-02-12 08:30U:ACOGFNews ReleaseAlpha Cognition Provides Business Update
2024-01-19 17:34U:ACOGFNews ReleaseAlpha Cognition Announces Final Closing of Private Placement Offering and Completion of the Overallotment
2023-12-22 16:32U:ACOGFNews ReleaseAlpha Cognition Announces Fourth Closing of Private Placement and Continuation of the Offering
2023-12-07 16:35U:ACOGFNews ReleaseAlpha Cognition Announces FDA Acceptance of New Drug Application for ALPHA-1062 for Mild-to-Moderate Alzheimer ¢ € ™s Disease
2023-12-04 20:00U:ACOGFNews ReleaseAlpha Cognition Announces Amended Terms of Private Placement and Continuation of the Offering